VISIBILITY STUDY definition

VISIBILITY STUDY. See Location Sketch (Page 3) Train Speed MPH Roadway Speed MPH Required Stopping Sight Distance (SSD) Along Roadway FEET Along Tracks FEET Reqd. Clearing Sight Dist. (CSD) (Along Tracks) FEET Distances calculated per American Association of State Highway and Transportation Officials (AASHTO), A Policy on Geometric Design of Highways and Streets, 2001, Fourth Edition. QUADRANT CSD (FT) OBSTRUCTION SSD (FT) OBSTRUCTION NE 100 Mature Crops in Adj. Field NW 50 Mature Crops in Adj. Field SE 100 Mature Crops in Adj. Field SW 100 Mature Crops in Adj. Field *Note: Automatic flashing light signals and gates (AFLSG) eliminate the need to satisfy minimum Sight Distance criteria. APPROACH GRADES: See Location Sketch (Page 3) DIRECTION/West DIRECTION/East DISTANCE (FT) ELEVATION (FT) GRADE (%) DISTANCE (FT) ELEVATION (FT) GRADE (%) 0 100’ --- 0 100’ --- Distance measured from outermost rail. COMMENTS: See Page 3 for a Location Sketch (Aerial Photo) of the crossing. Staff recommends that the GCPF be used pay 95% of the cost to install new automatic flashing lights signals & gates, event recorder, remote monitor, and track circuits, and that the UP pay all remaining installation costs. Staff also recommends that the Clinton Township Road District be required to pay 100% of the costs to install Advance Warning Signs (W10-1) along both roadway approaches to the crossing, per the minimum requirements of the Manual on Uniform Traffic Control Devices (MUTCD), current edition, and 92 Ill. Adm. Code 1535.310 (see Exhibit D). SA 2145 Exh. A, Page 3 Material And Force Account Estimate ICC Estimate Creation Date: 03/09/2021 Number: 133236 Version: 1 Estimate Good Until 03/09/22 Location: XXXX GROVE SUB, SIMN, 26.14-63.8 Buy America: Yes Description of Work: SHABBONA, IL, XXX ROAD, M.P. 37.17. XXXX GROVE SUBDIVISION, DOT#175778K, WO#58092, PID#116791, (95% ICC / 5% UPRR). COMMENTS Description QTY UOM Unit LABOR MATERIAL TOTAL UP 05% Cost SIGNAL Agncy 95% Xing - Engineering Design 1 LS 5,027.00 5,027 0 5,027 251 4,776 Xing - 1 Trk CWE w/Gates 1 EA 131,584.00 41,200 90,384 131,584 6,579 125,005 Xing - CAR14/24 (IL) 1 LS 6,482.00 3,840 2,642 6,482 324 6,158 Xing - Intermediate Signal 1 EA 13,165.00 5,536 7,629 13,165 658 12,507 Xing - IXS Track Circuit 1 EA 14,951.00 5,536 9,415 14,951 748 14,203 Xing - Meter Service 1 LS 15,000.00 0 15,000 15,000 750 14,250 Xing - Fill/Rock/Gravel 1 LS 5,000.00 0 5,000 5,000 250 4,750 Xing - Boring 1 LS 10,000.00 0 10,000 10,000 500 9,500 C-MIPP PROJ...
Sample 1
VISIBILITY STUDY. See Location Sketch Train Speed 49 MPH Roadway Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 483 FEET Along Tracks 504 FEET Required Clearing Sight Distance (CSD) (Along Tracks) 1174 FEET Distances calculated per American Association of State Highway and Transportation Officials (AASHTO), A Policy on Geometric Design of Highways and Streets, 2001, Fourth Edition. COMMENTS: Crossing Meets Profile Requirements See Page 3 for a Location Sketch (Aerial Photo) of the crossing. EXHIBIT A-1, PAGE 3 -- SA 1509 U.S. DOT#: 176904F Warning Device Description Type of Device: AFLS Number Of Devices: CrossBucks: 2 Cantelever: 0 Bells: 2 Gates: 0 WigWags: 0 Pedestrian Gates: 0 Flashing Lights Pairs: 4 Masts: 2 Mast Locations Edge of Road (Ft) Edge of Rail (Ft)
Sample 1
VISIBILITY STUDY. See Location Sketch Train Speed 25 MPH Roadway Speed 45 MPH Required Stopping Sight Distance (SSD) Along Roadway 388 FEET Along Tracks 256 FEET Required Clearing Sight Distance (CSD) (Along Tracks) 601 FEET Distances calculated per American Association of State Highway and Transportation Officials (AASHTO), A Policy on Geometric Design of Highways and Streets, 2001, Fourth Edition. QUADRANT CSD (FT) OBSTRUCTION SSD (FT) OBSTRUCTION NE ok none obstr* *tall crops may obstruct NW ok none obstr* *tall crops may obstruct SE ok none obstr* *tall crops may obstruct SW ok none obstr* *tall crops may obstruct *Note: Automatic flashing light signals and gates (AFLS&G) eliminate the need to satisfy minimum Sight Distance criteria. APPROACH GRADES2: See Page 3 DIRECTION/North DIRECTION/South DISTANCE (FT) ELEVATION (FT) GRADE (%) DISTANCE (FT) ELEVATION (FT) GRADE (%) 25 99.6 1.6% 25 98.8 4.8% 50 99.2 1.6% 50 97.1 6.8% Distance measured from outermost rail. COMMENTS: McLean County Highway Department (County) has estimated roadway approach costs, in the amount of $222,000, will be necessary to meet the minimum grade requirements of 92 Ill. Adm. Code 1535.204. Staff recommends that the Grade Crossing Protection Fund (GCPF) be used to pay 100% of the estimated approach costs, in an amount not to exceed $222,000. Staff considers the proposed approach improvements important enough to recommend that the GCPF be used to pay those costs.
Sample 1

Examples of VISIBILITY STUDY in a sentence

  • ADVANCE WARNING No PAVEMENT MARKING No RAILROAD DATA: See Location Sketch (Page 3) FREIGHT TRAFFIC 8/day @ 40 MPH PASSENGER TRAFFIC None WARNING DEVICES Crossbucks/YIELD Signs NOTES: VISIBILITY STUDY: See Location Sketch (Page 3) Train Speed 40 MPH Roadway Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 150 FEET Along Tracks 360 FEET Reqd.

  • Regardless, the government sustained its ownership and involvement at the operational level.

  • ADVANCE WARNING Yes PAVEMENT MARKING N/A – Oil and Chip RAILROAD DATA: See Location Sketch (Page 3) FREIGHT TRAFFIC 12/day @ 60 MPH PASSENGER TRAFFIC NO WARNING DEVICES Automatic Flashing Light Signals (AFLS), No Gates NOTES: SA 2298 Exhibit A1 VISIBILITY STUDY: See Location Sketch (Page 3) Train Speed 60 MPH Roadway Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 520 FEET Along Tracks 647 FEET Reqd.

  • ADVANCE WARNING YES PAVEMENT MARKING No RAILROAD DATA: See Location Sketch (Page 3) FREIGHT TRAFFIC 13/day @ 60 MPH PASSENGER TRAFFIC NO WARNING DEVICES Active Flashers NOTES: SA 2281 Exhibit A1 VISIBILITY STUDY: See Location Sketch (Page 3) Train Speed 60 MPH Roadway Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 520 FEET Along Tracks 647 FEET Reqd.

  • ADVANCE WARNING YES PAVEMENT MARKING No RAILROAD DATA: See Location Sketch (Page 3) FREIGHT TRAFFIC 13/day @ 60 MPH PASSENGER TRAFFIC NO WARNING DEVICES Active Flashers NOTES: SA 2281 Exhibit A2 VISIBILITY STUDY: See Location Sketch (Page 3) Train Speed 60 MPH Roadway Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 520 FEET Along Tracks 647 FEET Reqd.

  • ADVANCE WARNING Yes, on Both Approaches PAVEMENT MARKING None RAILROAD DATA: See Location Sketch FREIGHT TRAFFIC 19/day @ 60 MPH PASSENGER TRAFFIC None WARNING DEVICES AFLS/Crossbucks NOTES: VISIBILITY STUDY: See Location Sketch Train Speed 00 XXX Xxxxxxx Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 222 FEET Along Tracks 593 FEET Reqd.

  • VISIBILITY STUDY: See Location Sketch Train Speed 30 MPH Roadway Speed 30 MPH Required Stopping Sight Distance (SSD) Along Roadway 222 FEET Along Tracks 297 FEET Required Clearing Sight Distance (CSD) (Along Tracks) 721 FEET Distances calculated per American Association of State Highway and Transportation Officials (AASHTO), A Policy on Geometric Design of Highways and Streets, 2001, Fourth Edition.

  • VISIBILITY STUDY: See Location Sketch (Page 3) Train Speed MPH Roadway Speed MPH Required Stopping Sight Distance (SSD) Along Roadway FEET Along Tracks FEET Reqd.

  • ADVANCE WARNING No PAVEMENT MARKING No RAILROAD DATA: See Location Sketch (Page 3) FREIGHT TRAFFIC 7/day @ 50 MPH PASSENGER TRAFFIC None WARNING DEVICES Crossbucks/YIELD Signs NOTES: VISIBILITY STUDY: See Location Sketch (Page 3) Train Speed 40 MPH Roadway Speed 55 MPH Required Stopping Sight Distance (SSD) Along Roadway 150 FEET Along Tracks 360 FEET Reqd.

  • SA 2017 Exhibit A VISIBILITY STUDY: See Location Sketch Train Speed 10 MPH Roadway Speed 30 MPH Required Stopping Sight Distance (SSD) Along Roadway 222 FEET Along Tracks 99 FEET Required Clearing Sight Distance (CSD) (Along Tracks) 240 FEET Distances calculated per American Association of State Highway and Transportation Officials (AASHTO), A Policy on Geometric Design of Highways and Streets, 2001, Fourth Edition.

Related to VISIBILITY STUDY

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Feasibility Study means a comprehensive study of a deposit in which all geological, engineering, operating, economic and other relevant factors are considered in sufficient detail that it could reasonably serve as the basis for a final decision by a financial institution to finance the development of the deposit for mineral production;

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Generation Interconnection Feasibility Study means a study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Tariff, Part IV, section 36.2.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Firm Transmission Feasibility Study means a study conducted by the Transmission Provider in accordance with Tariff, Part II, section 19.3 and Tariff, Part III, section 32.3.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Development Area means that area to which a development plan is applicable.

  • System Impact Study means an assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights. System Protection Facilities: “System Protection Facilities” shall refer to the equipment required to protect (i) the Transmission System, other delivery systems and/or other generating systems connected to the Transmission System from faults or other electrical disturbance occurring at or on the Customer Facility, and (ii) the Customer Facility from faults or other electrical system disturbance occurring on the Transmission System or on other delivery systems and/or other generating systems to which the Transmission System is directly or indirectly connected. System Protection Facilities shall include such protective and regulating devices as are identified in the Applicable Technical Requirements and Standards or that are required by Applicable Laws and Regulations or other Applicable Standards, or as are otherwise necessary to protect personnel and equipment and to minimize deleterious effects to the Transmission System arising from the Customer Facility. Transmission Facilities:

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Interconnection Study means any of the studies defined in the CAISO’s Tariff or any Transmission/Distribution Owner’s tariff that reflect methodology and costs to interconnect the Facility to the Transmission/Distribution Owner’s electric grid.

  • Development Phase means the period before a vehicle type is type approved.

  • Project Scope means the description or activity of work to be accomplished on the project.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Interconnection Studies means the Interconnection Feasibility Study, the System Impact Study, and the Facilities Study described in Tariff, Part IV and Tariff, Part VI. Interface Pricing Point:

  • Development Work means the work of development to be performed on or with respect to the Land (including, without limitation, the installation of utilities, roads and all related on-site and off-site improvements) in connection with the development of the Land for the subsequent construction thereon of Homes, all of which work and construction shall be completed by or on behalf of the Borrower in accordance with the Plans and Specifications, but shall not include the Construction Improvements.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.